Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels
暂无分享,去创建一个
H. Kidoya | N. Takakura | T. Wakabayashi | H. Naito | S. Sakimoto | Hisamichi Naito | Taku Wakabayashi
[1] T. Suda,et al. Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. , 2011, Blood.
[2] S. Niclou,et al. Critical appraisal of the side population assay in stem cell and cancer stem cell research. , 2011, Cell stem cell.
[3] David S. Miller,et al. Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. , 2010, Trends in pharmacological sciences.
[4] Rachael J. Oakenfull,et al. Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.
[5] H. Kidoya,et al. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. , 2010, Blood.
[6] N. Galjart,et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium , 2010, Nature.
[7] H. Saya,et al. PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties. , 2010, Cancer research.
[8] Peter Carmeliet,et al. Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells , 2009, Journal of Molecular Medicine.
[9] Frederik De Smet,et al. Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.
[10] Zev Rosenwaks,et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. , 2009, Cell stem cell.
[11] M. Herlyn,et al. A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. , 2008, The Journal of clinical investigation.
[12] M. Majesky,et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells , 2008, Proceedings of the National Academy of Sciences.
[13] I. Weissman,et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.
[14] M. Brittan,et al. CD133: molecule of the moment , 2008, The Journal of pathology.
[15] D. Scheinberg,et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.
[16] G. Lip,et al. Endothelial progenitor cells in cardiovascular disorders. , 2007, Journal of the American College of Cardiology.
[17] H. Nakauchi,et al. Non-side-population hematopoietic stem cells in mouse bone marrow. , 2006, Blood.
[18] E. Bruscia,et al. Engraftment of Donor‐Derived Epithelial Cells in Multiple Organs Following Bone Marrow Transplantation into Newborn Mice , 2006, Stem cells.
[19] Lin Zhang,et al. Involvement of endothelial CD44 during in vivo angiogenesis. , 2006, The American journal of pathology.
[20] H. Lauke,et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis , 2006, Development.
[21] M. Little,et al. A Side Order of Stem Cells: The SP Phenotype , 2006, Stem cells.
[22] Stefanie Dimmeler,et al. Impaired CXCR4 Signaling Contributes to the Reduced Neovascularization Capacity of Endothelial Progenitor Cells From Patients With Coronary Artery Disease , 2005, Circulation research.
[23] A. Lafont,et al. Isolation of “Side Population” Progenitor Cells From Healthy Arteries of Adult Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[24] B. Peters,et al. Contribution of bone marrow–derived endothelial cells to human tumor vasculature , 2005, Nature Medicine.
[25] Mark A. Hall,et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. , 2004, Blood.
[26] C. Heyworth,et al. AC133+ G0 Cells from Cord Blood Show a High Incidence of Long‐Term Culture–Initiating Cells and a Capacity for More Than 100 Million‐Fold Amplification of Colony‐Forming Cells In Vitro , 2004, Stem cells.
[27] Keisuke Ito,et al. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.
[28] Qingbo Xu,et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. , 2004, The Journal of clinical investigation.
[29] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[30] X. Q. Zhang,et al. Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells. , 2001, Blood.
[31] N. Horseman,et al. Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by progesterone in mammary epithelium. , 2000, Endocrinology.
[32] T. Lu,et al. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. , 2000, Blood.
[33] T. Noda,et al. A Role for Hematopoietic Stem Cells in Promoting Angiogenesis , 2000, Cell.
[34] J. Isner,et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.
[35] Hiroshi Takahashi,et al. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.
[36] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[37] G. Yancopoulos,et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. , 1998, Immunity.
[38] S. Nishikawa,et al. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. , 1998, Immunity.
[39] M. Kennedy,et al. A common precursor for hematopoietic and endothelial cells. , 1998, Development.
[40] R. Pyatt,et al. Functional Heterogeneity of Human CD34+ Cells Isolated in Subcompartments of the G0 /G1 Phase of the Cell Cycle , 1997 .
[41] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[42] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[43] A. Murray,et al. Association of Spindle Assembly Checkpoint Component XMAD2 with Unattached Kinetochores , 1996, Science.
[44] Hiromitsu Nakauchi,et al. Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.
[45] A. S. Conner,et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.
[46] W. Risau. Differentiation of endothelium , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] T. Sun,et al. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.
[48] D. Beebe,et al. Hyaluronate in vasculogenesis. , 1983, Science.
[49] R. Kalluri,et al. Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.
[50] D. Hanahan,et al. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. , 1996, The Journal of clinical investigation.